about
A review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingPhosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factorsElevation of circulating big endothelin-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma.Functions of endothelin-1 in apoptosis and migration in hepatocellular carcinoma.Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arteriolesIdentification of a novel role for endothelins within the oviductThe host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular diseaseCre recombinase-regulated Endothelin1 transgenic mouse lines: novel tools for analysis of embryonic and adult disorders.FOXO1 mediates the autocrine effect of endothelin-1 on endothelial cell survival.The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications.Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer.New molecular targets in advanced prostate cancer.Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.Targeting the endothelin system: novel therapeutic options in gynecological, urological and breast cancers.The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.Novel options for the treatment of castration-resistant prostate cancer.Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletionEndothelin receptor A blockade enhances taxane effects in prostate cancer.Endothelin-1: a predictor of extracapsular extension in clinically localized prostate cancer?Endothelin-1 (ET-1) induces resistance to bortezomib in human multiple myeloma cells via a pathway involving the ETB receptor and upregulation of proteasomal activity.Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.Expression patterns of endothelin-1 and its receptors in colorectal cancer.Combination therapy of zibotentan with cisplatinum and paclitaxel is an effective regimen for epithelial ovarian cancer.Effect of endothelin-1 in esophageal squamous cell carcinoma invasion and its correlation with cathepsin B.Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation.Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.Atrasentan (ABT-627) enhances perfusion and reduces hypoxia in a human tumor xenograft model.Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome.Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy.Neoplasia: An Anniversary of Progress.Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia.High endothelin-converting enzyme-1 expression independently predicts poor survival of patients with esophageal squamous cell carcinoma.Endothelin-1 attenuates apoptosis in cultured trophoblasts from term human placentas.EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer.Therapeutic targeting of the endothelin a receptor in human nasopharyngeal carcinoma.Endothelin-1 Expression in Prostate Needle Biopsy Specimens Correlated With Aggressiveness of Prostatic Cancer.
P2860
Q28389391-FCA195EA-B05A-4F2D-9810-D6DAB95870E6Q28395095-096825C5-DC81-4661-A80B-88E9A6F3472DQ33316851-02F78845-7C7B-40F3-91CF-23EBCA43CEFDQ33384961-E8FDB934-E4C7-498B-887D-EEE122DFA5F1Q33744900-1392AD8E-30B8-4FD9-8AC9-272948F37B25Q33873953-2227E137-4AD7-491A-839C-B0362231F498Q33874386-5E55E5EA-4C2C-44C9-ACD0-43DE961D1B45Q34699785-73439FD3-2F60-4C8D-85DB-CDEC4A072316Q35086969-572270A0-B14B-469D-97AD-28A7AEBA1E66Q35268488-BB2C47D4-7493-43E4-953A-D9F3A33C315CQ36065490-82F15E26-C709-478F-8FC5-68980BFEF851Q36352082-8019F9A4-43DD-4095-9A97-CD1309EDE92EQ36368292-5FF4DD88-AB78-46E4-B410-53FAB3E5AF4EQ36532080-C09AE17A-4059-44FE-B0FC-0194867A8CE9Q36959649-CC759966-3391-4781-8A6B-E9F545099B6CQ37256842-EADA683B-7C27-4C01-8703-803F9ACA52E2Q37615017-A2D97C6E-51AA-43B5-A8C9-841EF8203980Q37958741-309315AE-A051-4C8C-8C88-175471423850Q38108308-A56C21C4-1B3B-488D-B4F4-07E0E2EC8651Q38273539-271F73BC-29F1-445A-972E-3D832B165359Q38413647-DD200596-77DD-4D98-AB03-0731A9B59346Q38751536-7DE9DF47-B24C-4373-B810-9223B7E1C8F8Q39398243-D31F48C6-3D5A-4CE0-B5A9-CB6C5895893EQ39418692-49539202-5B34-43C3-85BF-6201D3034F95Q39680529-F9DED1CA-AC3B-4E60-869B-001C29D48B19Q40100643-4E8C131F-51F9-40E2-B685-3D61DB768A5AQ40160207-36DA6F82-A05E-41F4-81B5-89181B8EC29DQ41083994-5BEB9C67-D3CF-4554-8679-327CBC113524Q41484298-1DE7A8E9-D922-41B3-8204-507CA6CB3745Q42786261-2730E79D-FCA7-4F3D-8E08-2665776C1BC6Q45855947-3B350F43-9D8C-426E-93B8-026F1CCE8269Q46932476-204BD023-AC38-4851-AA15-BE8CA26FEFBDQ47147169-27C8CE7B-85F8-46E2-AB86-45E55C52874DQ49849943-F4FD728C-5131-4925-853B-1CC4781FF250Q50897553-85F83902-0E5C-4FE6-BC55-F2D69EA136FBQ52666493-BB357C3A-77AE-4E07-A0F0-F1CBE9B4369DQ54577112-BE18B6EA-FB29-42B9-93DD-9E3EC1485221Q55237563-89EA321A-6EC3-4E6D-A470-0ED8EAEA0C9F
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Endothelin-1 inhibits apoptosis in prostate cancer
@ast
Endothelin-1 inhibits apoptosis in prostate cancer
@en
Endothelin-1 inhibits apoptosis in prostate cancer
@nl
type
label
Endothelin-1 inhibits apoptosis in prostate cancer
@ast
Endothelin-1 inhibits apoptosis in prostate cancer
@en
Endothelin-1 inhibits apoptosis in prostate cancer
@nl
prefLabel
Endothelin-1 inhibits apoptosis in prostate cancer
@ast
Endothelin-1 inhibits apoptosis in prostate cancer
@en
Endothelin-1 inhibits apoptosis in prostate cancer
@nl
P2093
P2860
P356
P1433
P1476
Endothelin-1 inhibits apoptosis in prostate cancer
@en
P2093
Beth R Pflug
Georgi Guruli
Joel B Nelson
Michael S Udan
P2860
P304
P356
10.1593/NEO.04787
P577
2005-07-01T00:00:00Z